Patents by Inventor Hervé Poulet

Hervé Poulet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant viral vector systems expressing exogenous feline paramyxovirus genes and vaccines made therefrom
    Patent number: 11033616
    Abstract: The present invention relates to exogenous feline paramyxovirus genes, which are expressed from recombinant viral vector systems.
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: June 15, 2021
    Inventors: Hervé Poulet, Veljko Nikolin, Abraham Johannes De Smit, Teshome Mebatsion
  • RECOMBINANT VIRAL VECTOR SYSTEMS EXPRESSING EXOGENOUS FELINE PARAMYXOVIRUS GENES AND VACCINES MADE THEREFROM
    Publication number: 20200206339
    Abstract: The present invention relates to exogenous feline paramyxovirus genes, which are expressed from recombinant viral vector systems.
    Type: Application
    Filed: February 20, 2019
    Publication date: July 2, 2020
    Inventors: Hervé POULET, Veljko NIKOLIN, Abraham Johannes DE SMIT, Teshome MEBATSION
  • Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
    Patent number: 8895027
    Abstract: The present invention provides vectors that contain and express in vivo or in vitro FeLV antigens that elicit an immune response in animal or human against FeLV, compositions comprising said vectors and/or FeLV polypeptides, methods of vaccination against FeLV, and kits for use with such methods and compositions.
    Type: Grant
    Filed: February 2, 2012
    Date of Patent: November 25, 2014
    Assignees: Merial Limited, Centre National de la Recherche Scientifique, Institut Gustave Roussy, Universite Paris-Sud
    Inventors: Hervé Poulet, Thierry Heidmann
  • RECOMBINANT FELINE LEUKEMIA VIRUS VACCINE CONTAINING OPTIMIZED FELINE LEUKEMIA VIRUS ENVELOPE GENE
    Publication number: 20130022632
    Abstract: The present invention provides vectors that contain and express in vivo or in vitro FeLV antigens that elicit an immune response in animal or human against FeLV, compositions comprising said vectors and/or FeLV polypeptides, methods of vaccination against FeLV, and kits for use with such methods and compositions.
    Type: Application
    Filed: February 2, 2012
    Publication date: January 24, 2013
    Inventors: Hervé Poulet, Thierry Heidmann
  • RECOMBINANT FELINE LEUKEMIA VIRUS VACCINE CONTAINING OPTIMIZED FELINE LEUKEMIA VIRUS ENVELOPE GENE
    Publication number: 20120183569
    Abstract: The present invention provides vectors that contain and express in vivo or in vitro FeLV antigens that elicit an immune response in animal or human against FeLV, compositions comprising said vectors and/or FeLV polypeptides, methods of vaccination against FeLV, and kits for use with such methods and compositions.
    Type: Application
    Filed: February 2, 2012
    Publication date: July 19, 2012
    Inventors: Hervé Poulet, Thierry Heidmann
  • Feline vaccines against avian influenza
    Patent number: 7910112
    Abstract: The present invention encompasses influenza vaccines, in particular avian influenza vaccines. The vaccine may be a recombinant poxvirus vaccine or an inactivated vaccine. The invention also encompasses recombinant poxvirus vectors encoding and expressing avian influenza antigens, epitopes or immunogens which can be used to protect animals, in particular felids, against avian influenza.
    Type: Grant
    Filed: November 6, 2006
    Date of Patent: March 22, 2011
    Assignee: Merial Limited
    Inventors: Hervé Poulet, Jean Christophe Audonnet, Michel Bublot, Jiansheng Yao
  • Vaccine against feline calicivirus
    Patent number: 7850978
    Abstract: The present invention relates to improved methods and immunogenic and/or vaccine compositions for providing an immune response to feline calicivirus, including hypervirulent strains of feline calicivirus.
    Type: Grant
    Filed: January 21, 2005
    Date of Patent: December 14, 2010
    Assignee: Merial Limited
    Inventors: Hervé Poulet, Frederic Raymond David
  • Vaccination against canine herpesvirosis and vaccines therefor
    Patent number: 6551598
    Abstract: Use of a CHV antigen for the preparation of a vaccine against canine herpesvirosis, which is intended to be administered to gestating bitches as close as possible to whelping, preferably during the final third of gestation, and which produces a high level of anti-CHV antibodies in gestating bitches at the time of whelping, inducing protection in the puppies by transfer of antibodies during suckling. Inactivated anti-CHV vaccine or subunit vaccines, which can be used for vaccinating gestating bitches to protect the puppies by transfer of antibodies.
    Type: Grant
    Filed: January 18, 2001
    Date of Patent: April 22, 2003
    Assignee: Merial
    Inventor: Hervé Poulet